FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Chiun Hsu

Research Profile

Disorders

Procedures

Chemicals & Drugs

Concepts & Ideas

Geographic Areas

Taiwan

Co-author Network

Publications

TOP 3
Y-C Shen; C-Y Chang; Chiun Hsu; C-Y Lin; K-L Lin; S-H Liu; D-L Ou; Ann-Lii Cheng
Activating oxidative phosphorylation by a pyruvate dehydrogenase kinase inhibitor overcomes sorafenib resistance of hepatocellular carcinoma.
Tzu-An Liu; John Wang; Yao-Ming Wu; Shyh-Chang Chen; Chiun Hsu; Yee-Jee Jan; Bor-Sheng Ko; Shu-Man Liang; Jun-Yang Liou
14-3-3ε overexpression contributes to epithelial-mesenchymal transition of hepatocellular carcinoma.
Yi-Yuan Shao; Y-C Shen; Chiun Hsu; Chih-Hung Hsu; Z-Z Lin; L-C Lu; Ann-Lii Cheng
Prognosis of advanced hepatocellular carcinoma patients enrolled in clinical trials can be classified by current staging systems.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Chiun Hsu (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Y-C Shen; C-Y Chang; Chiun Hsu; C-Y Lin; K-L Lin; S-H Liu; D-L Ou; Ann-Lii Cheng
Activating oxidative phosphorylation by a pyruvate dehydrogenase kinase inhibitor overcomes sorafenib resistance of hepatocellular carcinoma.
British journal of cancer 2013;108(1):72-81.
2013: Tzu-An Liu; John Wang; Yao-Ming Wu; Shyh-Chang Chen; Chiun Hsu; Yee-Jee Jan; Bor-Sheng Ko; Shu-Man Liang; Jun-Yang Liou
14-3-3ε overexpression contributes to epithelial-mesenchymal transition of hepatocellular carcinoma.
PloS one 2013;8(3):e57968.
2012: Yi-Yuan Shao; Y-C Shen; Chiun Hsu; Chih-Hung Hsu; Z-Z Lin; L-C Lu; Ann-Lii Cheng
Prognosis of advanced hepatocellular carcinoma patients enrolled in clinical trials can be classified by current staging systems.
British journal of cancer 2012;107(10):1672-7.
2012: Tzu-Hsueh Yang; Chiun Hsu; Shih-Hua Huang; Da-Liang Ou; Po-Ling Chang
Comparative microRNA detection from precursor-microRNA-transfected hepatocellular carcinoma cells by capillary electrophoresis with dual-color laser-induced fluorescence.
Electrophoresis 2012;33(17):2769-76.
2012: Li-Chun Lu; Yu-Yun Shao; Ann-Lii Cheng; Wen-Fang Cheng; Chiun Hsu; Chih-Hung Hsu; Yu-Lin Lin; Kun-Huei Yeh
Metastasectomy of Krukenberg tumors may be associated with survival benefits in patients with metastatic gastric cancer.
Anticancer research 2012;32(8):3397-401.
2012: Chiun Hsu; Wen-Tsung Huang; Teh-Ia Huo; Wei-Shou Hwang; Robin Meng; Tsai-Sheng Yang; Chih-Wei Yu; Yee Chao; Ruey-Kuen Hsieh; Tsai-Yuan Hsieh; Ann-Lii Cheng
Vandetanib in patients with inoperable hepatocellular carcinoma: a phase II, randomized, double-blind, placebo-controlled study.
Journal of hepatology 2012;56(5):1097-103.
2012: Hui-Ju Ch'ang; Jeffrey S Chang; Ya-Hui Chang; Chien-Hung Chen; Chiun Hsu; Li-Tzong Chen
Phase II study of concomitant thalidomide during radiotherapy for hepatocellular carcinoma.
International journal of radiation oncology, biology, physics 2012;82(2):817-25.
2012: Zhong-Zhe Lin; Yu-Yun Shao; Chih-Hsin Yang; Dwan-Ying Chang; Ruey-Long Hong; Chiun Hsu; Chih-Hung Hsu; Fu-Chang Hu; Ann-Lii Cheng
Factors impacting prognosis prediction in BCLC stage C and Child-Pugh class A hepatocellular carcinoma patients in prospective clinical trials of systemic therapy.
The oncologist 2012;17(7):970-7.
2012: Wen-Yi Shau; Yi-Chun Yeh; Zhong-Zhe Lin; Yu-Yun Shao; Ann-Lii Cheng; Chiun Hsu; Chih-Hung Hsu; Raymond Kuo; Mei-Shu Lai
Diabetes mellitus is associated with increased mortality in patients receiving curative therapy for hepatocellular carcinoma.
The oncologist 2012;17(6):856-62.
2012: Ying-Chun Shen; Chia-Chi Cheng; Chiun Hsu; Fu-Chang Hu; Ann-Lii Cheng
A critical evaluation of the preventive effect of antiviral therapy on the development of hepatocellular carcinoma in patients with chronic hepatitis C or B: a novel approach by using meta-regression.
Oncology 2012;82(5):275-89.
2012: Yu-Yun Shao; Yin-Chun Shen; Chi-Huang Hsiao; Chiun Hsu; Chih-Hung Hsu; Chien-Chung Huang; Kuan-Der Lee; Zhong-Zhe Lin; Yen-Shen Lu; Ann-Lii Cheng
Efficacy, safety, and potential biomarkers of thalidomide plus metronomic chemotherapy for advanced hepatocellular carcinoma.
Oncology 2012;82(1):59-66.
2011: Chiun Hsu
End-of-life care for cancer patients in Taiwan.
Journal of the Formosan Medical Association = Taiwan yi zhi 2011;110(12):799.
2011: Tzu-An Liu; Tang-Long Shen; Song-Kun Shyue; John Wang; Pei-Feng Chen; Shyh-Chang Chen; Chiun Hsu; Ya-Lin Hung; Yee-Jee Jan; Bor-Sheng Ko; Yen-Ming Lee; Shu-Man Liang; Jun-Yang Liou
Increased expression of 14-3-3β promotes tumor progression and predicts extrahepatic metastasis and worse survival in hepatocellular carcinoma.
The American journal of pathology 2011;179(6):2698-708.
2011: I C Chen; Chiun Hsu; C S Huang; W H Kuo; H C Lien; C H Lin; Y S Lu; A L Cheng
Lack of efficacy to systemic chemotherapy for treatment of metaplastic carcinoma of the breast in the modern era.
Breast cancer research and treatment 2011;130(1):345-51.
2011: Chao-Yu Hsu; Fu-Chang Hu; Ying-Chun Shen; Bang-Bin Chen; Ann-Lii Cheng; Chiun Hsu; Chih-Hung Hsu; Shwu-Yuan Wei; Chih-Wei Yu; Tiffany Ting-Fang Shih
Dynamic contrast-enhanced magnetic resonance imaging biomarkers predict survival and response in hepatocellular carcinoma patients treated with sorafenib and metronomic tegafur/uracil.
Journal of hepatology 2011;55(4):858-65.
2011: Bor-Sheng Ko; Tzu-Ching Chang; Chiun Hsu; Yao-Chang Chen; Tang-Long Shen; Shyh-Chang Chen; John Wang; Kenneth K Wu; Yee-Jee Jan; Jun-Yang Liou
Overexpression of 14-3-3ε predicts tumour metastasis and poor survival in hepatocellular carcinoma.
Histopathology 2011;58(5):705-11.
2011: Mei-Fang Cheng; Yen-Wen Wu; Kao-Lang Liu; Ruoh-Fang Yen; Yao-Ming Wu; Chiun Hsu; Yu-Ting Chang; Kai-Yuan Tzen; Hsiu-Po Wang
Diagnostic value of 18F-FDG-PET/CT in indeterminate infiltrative hepatic lesions in an endemic area of viral hepatitis.
Nuclear medicine communications 2011;32(4):252-9.
2011: Yu-Yun Shao; Ying-Chun Shen; Te-Jung Chen; Chiun Hsu; Chih-Hung Hsu; Zhong-Zhe Lin; Ann-Lii Cheng
High circulating endothelial progenitor levels associated with poor survival of advanced hepatocellular carcinoma patients receiving sorafenib combined with metronomic chemotherapy.
Oncology 2011;81(2):98-103.
2010: Da-Liang Ou; Ying-Chun Shen; Sung-Liang Yu; Kuen-Feng Chen; Pei-Yen Yeh; Hsiang-Hsuan Fan; Wen-Chi Feng; Ching-Tzu Wang; Liang-In Lin; Chiun Hsu; Ann-Lii Cheng
Induction of DNA damage-inducible gene GADD45beta contributes to sorafenib-induced apoptosis in hepatocellular carcinoma cells.
Cancer research 2010;70(22):9309-18.
2010: Pei-Jer Chen; Junji Furuse; Kwang-Hyub Han; Chiun Hsu; Ho-Yeong Lim; Hanlim Moon; Shukui Qin; Sheng-Long Ye; Ee-Min Yeoh; Winnie Yeo
Issues and controversies of hepatocellular carcinoma-targeted therapy clinical trials in Asia: experts' opinion.
Liver international : official journal of the International Association for the Study of the Liver 2010;30(10):1427-38.
2010: Yu-Yun Shao; Zhong-Zhe Lin; Chiun Hsu; Ying-Chun Shen; Chih-Hung Hsu; Ann-Lii Cheng
Early alpha-fetoprotein response predicts treatment efficacy of antiangiogenic systemic therapy in patients with advanced hepatocellular carcinoma.
Cancer 2010;116(19):4590-6.
2010: Ying-Chun Shen; Chiun Hsu; Ann-Lii Cheng
Molecular targeted therapy for advanced hepatocellular carcinoma: current status and future perspectives.
Journal of gastroenterology 2010;45(8):794-807.
2010: Chih-Hung Hsu; Ying-Chun Shen; Zhong-Zhe Lin; Pei-Jer Chen; Yu-Yun Shao; Yea-Hui Ding; Chiun Hsu; Ann-Lii Cheng
Phase II study of combining sorafenib with metronomic tegafur/uracil for advanced hepatocellular carcinoma.
Journal of hepatology 2010;53(1):126-31.
2010: Ying-Chun Shen; Chiun Hsu; Li-Tzong Chen; Chia-Chi Cheng; Fu-Chang Hu; Ann-Lii Cheng
Adjuvant interferon therapy after curative therapy for hepatocellular carcinoma (HCC): a meta-regression approach.
Journal of hepatology 2010;52(6):889-94.
2010: Yu-Yun Shao; Kuan-Ting Kuo; Fu-Chang Hu; Yen-Shen Lu; Chiun-Sheng Huang; Jau-Yu Liau; Wei-Chung Lee; Chiun Hsu; Wun-Hon Kuo; King-Jeng Chang; Ching-Hung Lin; Ann-Lii Cheng
Predictive and prognostic values of tau and ERCC1 in advanced breast cancer patients treated with paclitaxel and cisplatin.
Japanese journal of clinical oncology 2010;40(4):286-93.
2010: Chih-Hung Hsu; T-S Yang; Chiun Hsu; H C Toh; R J Epstein; L-T Hsiao; P-J Chen; Z-Z Lin; Tsu-Yi Chao; Ann-Lii Cheng
Efficacy and tolerability of bevacizumab plus capecitabine as first-line therapy in patients with advanced hepatocellular carcinoma.
British journal of cancer 2010;102(6):981-6.
2010: Bor-Sheng Ko; Tzu-Ching Chang; Chien-Hung Chen; Chia-Chia Liu; Cheng-Chin Kuo; Chiun Hsu; Ying-Chun Shen; Tang-Long Shen; Vita M Golubovskaya; Chung-Che Chang; Song-Kun Shyue; Jun-Yang Liou
Bortezomib suppresses focal adhesion kinase expression via interrupting nuclear factor-kappa B.
Life sciences 2010;86(5-6):199-206.
2010: Winnie Yeo; Pei-Jer Chen; Junji Furuse; Kwang-Hyub Han; Chiun Hsu; Ho-Yeong Lim; Hanlim Moon; Shukui Qin; Ee-Min Yeoh; Sheng-Long Ye
Eastern Asian expert panel opinion: designing clinical trials of molecular targeted therapy for hepatocellular carcinoma.
BMC cancer 2010;10():620.
2010: Chiun Hsu; Ying-Chun Shen; Chia-Chi Cheng; Fu-Chang Hu; Ann-Lii Cheng
Geographic difference in survival outcome for advanced hepatocellular carcinoma: implications on future clinical trial design.
Contemporary clinical trials 2010;31(1):55-61.
2009: Yee-Jee Jan; Bor-Sheng Ko; Chiun Hsu; Tzu-Ching Chang; Shyh-Chang Chen; John Wang; Jun-Yang Liou
Overexpressed focal adhesion kinase predicts a higher incidence of extrahepatic metastasis and worse survival in hepatocellular carcinoma.
Human pathology 2009;40(10):1384-90.
2009: Da-Liang Ou; Ying-Chun Shen; Ja-Der Liang; Jun-Yang Liou; Sung-Liang Yu; Hsiang-Hsuan Fan; Da-Sheng Wang; Yen-Shen Lu; Chiun Hsu; Ann-Lii Cheng
Induction of Bim expression contributes to the antitumor synergy between sorafenib and mitogen-activated protein kinase/extracellular signal-regulated kinase kinase inhibitor CI-1040 in hepatocellular carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(18):5820-8.
2009: Chiun Hsu; Shu-Chen Wei; Ann-Lii Cheng; Pei-Jer Chen
Strategies to prevent hepatitis B virus reactivation in patients receiving immunosuppressive therapy.
Hepatology (Baltimore, Md.) 2009;50(2):654-5.
2009: Chiun Hsu; Ann-Lii Cheng; Pei-Jer Chen
Lamivudine and hepatitis B reactivation.
Annals of internal medicine 2009;151(2):141; author reply 141-2.
2009: Kuen-Feng Chen; Pei-Yen Yeh; Chiun Hsu; Chih-Hung Hsu; Yen-Shen Lu; Hsing-Pang Hsieh; Pei-Jer Chen; Ann-Lii Cheng
Bortezomib overcomes tumor necrosis factor-related apoptosis-inducing ligand resistance in hepatocellular carcinoma cells in part through the inhibition of the phosphatidylinositol 3-kinase/Akt pathway.
The Journal of biological chemistry 2009;284(17):11121-33.
2009: Zhong-Zhe Lin; Hey-Chi Hsu; Chih-Hung Hsu; Pei-Yen Yeh; Chi-Ying F Huang; Yung-Feng Huang; Te-Jung Chen; Sung-Hsin Kuo; Chiun Hsu; Fu-Chang Hu; Yung-Ming Jeng; Ying Chung; Ann-Lii Cheng
The Aurora kinase inhibitor VE-465 has anticancer effects in pre-clinical studies of human hepatocellular carcinoma.
Journal of hepatology 2009;50(3):518-27.
2009: Ying-Chun Shen; Fu-Chang Hu; Yung-Ming Jeng; Yu-Ting Chang; Zhong-Zhe Lin; Ming-Chu Chang; Chiun Hsu; Ann-Lii Cheng
Nuclear overexpression of mitotic regulatory proteins in biliary tract cancer: correlation with clinicopathologic features and patient survival.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2009;18(2):417-23.
2008: Chiun Hsu; Sow-Hsong Kuo; Fu-Chang Hu; Ann-Lii Cheng; Jin-Yuan Shih; Chong-Jen Yu; Chia-Chi Lin; Tsu-Chen Huang; Pan-Chyr Yang; Chih-Hsin Yang
Gemcitabine plus conventional-dose epirubicin versus gemcitabine plus cisplatin as first-line chemotherapy for stage IIIB/IV non-small cell lung carcinoma--a randomized phase II trial.
Lung cancer (Amsterdam, Netherlands) 2008;62(3):334-43.
2008: Yu-Ting Chang; Ming-Chu Chang; Shu-Chen Wei; Yu-Wen Tien; Chiun Hsu; Po-Chin Liang; Po-Nien Tsao; I-Shiow Jan; Jau-Min Wong
Serum vascular endothelial growth factor/soluble vascular endothelial growth factor receptor 1 ratio is an independent prognostic marker in pancreatic cancer.
Pancreas 2008;37(2):145-50.
2008: Sheng-Mou Hsiao; Chi-An Chen; Chiun Hsu; Ho-Hsiung Lin; Chang-Yao Hsieh; Lin-Hung Wei
Weekly cisplatin, infusional high-dose 5-fluorouracil and leucovorin for advanced, recurrent and metastatic cervical carcinoma.
Anticancer research 2008;28(3B):1887-91.
2008: Zhong-Zhe Lin; Chiun Hsu; Yeun-Chung Chang; Chong-Jen Yu; Chih-Hung Hsu; Chia-Chi Lin; Ann-Lii Cheng; Pan-Chyr Yang; Chih-Hsin Yang
Outcome of advanced nonsmall cell lung cancer patients receiving gemcitabine and weekly paclitaxel as first-line treatment.
Lung cancer (Amsterdam, Netherlands) 2008;60(2):215-21.
2008: Jo-Pai Chen; Yin Lo; Chong-Jen Yu; Chiun Hsu; Jin-Yuan Shih; Chih-Hsin Yang
Predictors of toxicity of weekly docetaxel in chemotherapy-treated non-small cell lung cancers.
Lung cancer (Amsterdam, Netherlands) 2008;60(1):92-7.
2008: Chiun Hsu; Chao A Hsiung; Ih-Jen Su; Wei-Shou Hwang; Ming-Chung Wang; Sheng-Fung Lin; Tseng-Hsi Lin; Hui-Hua Hsiao; Ji-Hsiung Young; Ming-Chih Chang; Yu-Min Liao; Chi-Cheng Li; Hung-Bo Wu; Hwei-Fang Tien; Tsu-Yi Chao; Tsang-Wu Liu; Ann-Lii Cheng; Pei-Jer Chen
A revisit of prophylactic lamivudine for chemotherapy-associated hepatitis B reactivation in non-Hodgkin's lymphoma: a randomized trial.
Hepatology (Baltimore, Md.) 2008;47(3):844-53.
2008: Yiyu Zou; Wen-Bin Tsai; Chien-Jui Cheng; Chiun Hsu; Young Min Chung; Pao-Chen Li; Sue-Hwa Lin; Mickey C-T Hu
Forkhead box transcription factor FOXO3a suppresses estrogen-dependent breast cancer cell proliferation and tumorigenesis.
Breast cancer research : BCR 2008;10(1):R21.
2007: Chia-Chi Lin; Kun-Huei Yeh; Chih-Hsin Yang; Chiun Hsu; Yu-Chieh Tsai; Wei-Ling Hsu; Ann-Lii Cheng; Chih-Hung Hsu
Multifractionated paclitaxel and cisplatin combined with 5-fluorouracil and leucovorin in patients with metastatic or recurrent esophageal squamous cell carcinoma.
Anti-cancer drugs 2007;18(6):703-8.
2007: Po-Chin Liang; Hui-Ju Ch'ang; Chiun Hsu; Shuo Shuo Tseng; Tiffany T F Shih; Tsang Wu Liu
Dynamic MRI signals in the second week of radiotherapy relate to treatment outcomes of hepatocellular carcinoma: a preliminary result.
Liver international : official journal of the International Association for the Study of the Liver 2007;27(4):516-28.
2007: Yu-Ting Chang; Chiun Hsu; Yung-Ming Jeng; Ming-Chu Chang; Shu-Chen Wei; Jau-Min Wong
Expression of the caudal-type homeodomain transcription factor CDX2 is related to clinical outcome in biliary tract carcinoma.
Journal of gastroenterology and hepatology 2007;22(3):389-94.
2007: Chia-Chi Lin; Chiun Hsu; Chih-Hung Hsu; Wei-Ling Hsu; Ann-Lii Cheng; Chih-Hsin Yang
Arsenic trioxide in patients with hepatocellular carcinoma: a phase II trial.
Investigational new drugs 2007;25(1):77-84.
2007: Chia-Chi Lin; Ann-Lii Cheng; Chih-Hung Hsu; Yen-Shen Lu; Chiun Hsu; Kun-Huei Yeh; Chen-Yao Wu; Chiun-Sheng Huang; Chih-Hsin Yang
A phase II trial of weekly paclitaxel and high-dose 5-fluorouracil plus leucovorin in patients with chemotherapy-pretreated metastatic breast cancer.
Anticancer research 2007;27(1B):641-5.
2006: Chih-Hsin Yang; Jin-Yuan Shih; Kun-Chieh Chen; Chong-Jen Yu; Tsung-Ying Yang; Ching-Pei Lin; Wen-Pin Su; Chien-Hung Gow; Chiun Hsu; Gee-Chen Chang; Pan-Chyr Yang
Survival outcome and predictors of gefitinib antitumor activity in East Asian chemonaive patients with advanced nonsmall cell lung cancer.
Cancer 2006;107(8):1873-82.
2006: Hui-Ju Ch'ang; Chuan-Cheng Wang; Ann-Lii Cheng; Chiun Hsu; Yen-Shen Lu; Ming-Chu Chang; Jaw-Town Lin; Hsiu-Po Wang; Her-Shyong Shiah; Tsang-Wu Liu; Jang-Yang Chang; Jacqueline Whang-Peng; Li-Tzong Chen
Phase I study of biweekly gemcitabine followed by oxaliplatin and simplified 48-h infusion of fluorouracil/leucovorin for advanced pancreatic cancer.
Journal of gastroenterology and hepatology 2006;21(5):874-9.
2006: Chiun Hsu; Ying-Chun Shen; Chia-Chi Cheng; Ruey-Long Hong; Chee-Jen Chang; Ann-Lii Cheng
Difference in the incidence trend of nasopharyngeal and oropharyngeal carcinomas in Taiwan: implication from age-period-cohort analysis.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2006;15(5):856-61.
2006: Min-Cheng Su; Chiun Hsu; Hsin-Lien Kao; Yung-Ming Jeng
CD24 expression is a prognostic factor in intrahepatic cholangiocarcinoma.
Cancer letters 2006;235(1):34-9.
2006: Her-Shyong Shiah; Ann-Lii Cheng; Chiun Hsu; Chih-Hung Hsu; Tsang-Wu Liu; Jang-Yang Chang; Chang-Ming Jan; Yee Chao; Wei-Lan Yu; Tsai-Rong Chuang; Jacqueline Whang-Peng; Li-Tzong Chen
Phase I-II trial of weekly gemcitabine plus high-dose 5-fluorouracil and leucovorin in advanced pancreatic cancer.
Journal of gastroenterology and hepatology 2006;21(3):531-6.
2005: Ching-Hung Lin; Ruoh-Fang Yen; Yung-Ming Jeng; Chin-Yuan Tzen; Chiun Hsu; Ruey-Long Hong
Unexpected rapid progression of metastatic adenoid cystic carcinoma during treatment with imatinib mesylate.
Head & neck 2005;27(12):1022-7.
2005: Wen-Pin Su; Chi-Chung Wen; Chao A Hsiung; Ih-Jen Su; Ann-Lii Cheng; Ming-Chih Chang; Chao-Jung Tsao; Woei-Yau Kao; Wu-Ching Uen; Chiun Hsu; Chih-Hung Hsu; Yen-Shen Lu; Hwei-Fang Tien; Tsu-Yi Chao; Li-Tzong Chen; Jacqueline Whang-Peng; Pei-Jer Chen
Long-term hepatic consequences of chemotherapy-related HBV reactivation in lymphoma patients.
World journal of gastroenterology : WJG 2005;11(34):5283-8.
2005: Wen-Pin Su; Chih-Hsin Yang; Chong-Jen Yu; Jin-Yuan Shih; Chiun Hsu; Pan-Chyr Yang
Gefitinib treatment for non-small cell lung cancer -- a study including patients with poor performance status.
Journal of the Formosan Medical Association = Taiwan yi zhi 2005;104(8):557-62.
2005: Ying-Chun Shen; Chee-Jen Chang; Chiun Hsu; Chia-Chi Cheng; Chang-Fang Chiu; Ann-Lii Cheng
Significant difference in the trends of female breast cancer incidence between Taiwanese and Caucasian Americans: implications from age-period-cohort analysis.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2005;14(8):1986-90.
2005: Chiun Hsu; Chiung-Nien Chen; Li-Tzong Chen; Chen-Yao Wu; Fon-Jou Hsieh; Ann-Lii Cheng
Effect of thalidomide in hepatocellular carcinoma: assessment with power doppler US and analysis of circulating angiogenic factors.
Radiology 2005;235(2):509-16.
2005: Sow-Hsong Kuo; Chih-Hsin Yang; Chong-Jen Yu; Chiun Hsu; Ann-Lii Cheng; Pan-Chyr Yang
Survival of stage IIIB/IV non-small cell lung cancer patients who received chemotherapy but did not participate in clinical trials.
Lung cancer (Amsterdam, Netherlands) 2005;48(2):275-80.
2005: Kun-Huei Yeh; Yen-Shen Lu; Chih-Hung Hsu; Jing-Fang Lin; Chiun Hsu; Sow-Hsong Kuo; Shiou-Jr Li; Ann-Lii Cheng
Phase II study of weekly paclitaxel and 24-hour infusion of high-dose 5-fluorouracil and leucovorin in the treatment of recurrent or metastatic gastric cancer.
Oncology 2005;69(1):88-95.
2004: Y-C Shen; Chiun Hsu; Jen-Yang Chen; Ann-Lii Cheng
Lack of efficacy of troglitazone at clinically achievable concentrations, with or without 9-cis retinoic acid or cytotoxic agents, for hepatocellular carcinoma cell lines.
British journal of cancer 2004;91(8):1561-5.
2004: Chiun Hsu; Jason Chia-Hsien Cheng; Ann-Lii Cheng
Recent advances in non-surgical treatment for advanced hepatocellular carcinoma.
Journal of the Formosan Medical Association = Taiwan yi zhi 2004;103(7):483-95.
2004: Chiun Hsu; Y-C Shen; Chang-Hao Yang; Kun-Huei Yeh; Yen-Shen Lu; Chih-Hung Hsu; H-T Liu; Chi-Cheng Li; J-S Chen; Chen-Yao Wu; Ann-Lii Cheng
Weekly gemcitabine plus 24-h infusion of high-dose 5-fluorouracil/leucovorin for locally advanced or metastatic carcinoma of the biliary tract.
British journal of cancer 2004;90(9):1715-9.
2004: Yen-Shen Lu; Chiun Hsu; Chi-Cheng Li; Sow-Hsong Kuo; Kun-Huei Yeh; Chih-Hsin Yang; Chih-Hung Hsu; Chen-Yao Wu; Ann-Lii Cheng
Phase II study of combination doxorubicin, interferon-alpha, and high-dose tamoxifen treatment for advanced hepatocellular carcinoma.
Hepato-gastroenterology 2004;51(57):815-9.
2004: Wei-Chu Chie; Chih-Hsin Yang; Chiun Hsu; Pan-Chyr Yang
Quality of life of lung cancer patients: validation of the Taiwan Chinese version of the EORTC QLQ-C30 and QLQ-LC13.
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 2004;13(1):257-62.
2003: Chiun Hsu; Jung-Der Wang; Jing-Shiang Hwang; Hwei-Fang Tien; Shueh-Mei Chang; Ann-Lii Cheng; Yao-Chang Chen; Jih-Luh Tang
Survival-weighted health profile for long-term survivors of acute myelogenous leukemia.
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 2003;12(5):503-17.
2003: Chiun Hsu; Chiung-Nien Chen; Li-Tzong Chen; Chen-Yao Wu; Pei-Ming Yang; Ming-Yang Lai; Po-Huang Lee; Ann-Lii Cheng
Low-dose thalidomide treatment for advanced hepatocellular carcinoma.
Oncology 2003;65(3):242-9.
2002: Chiun Hsu; Chiun-Sheng Huang; Tsu-Yi Chao; Yen-Shen Lu; Ching-Fang Bu; Mary M Chen; King-Jen Chang; Ann-Lii Cheng
Phase II trial combining paclitaxel with 24-hour infusion cisplatin for chemotherapy-naïve patients with locally advanced or metastatic breast carcinoma.
Cancer 2002;95(10):2044-50.
2002: Chih-Hung Hsu; Ann-Lii Cheng; Chiun Hsu; Chih-Hsin Yang; Yen-Shen Lu; Chia-Chi Lin; Ching-Fang Bu; Kun-Huei Yeh
A phase II study of weekly methotrexate, cisplatin, and 24-hour infusion of high-dose 5-fluorouracil and leucovorin (MP-HDFL) in patients with metastatic and recurrent esophageal cancer-improving toxicity profile by infusional schedule and double biochemical modulation of 5-fluorouracil.
Anticancer research 2002;22(6B):3621-7.
2002: Chang-Hao Yang; C M Tsai; L S Wang; Yung-Chie Lee; C J Chang; L T Lui; Sang-Hue Yen; Chiun Hsu; Ann-Lii Cheng; M Y Liu; S C Chiang; Y M Chen; K T Luh; M H Huang; P-C Yang; Reury-Perng Perng
Gemcitabine and cisplatin in a multimodality treatment for locally advanced non-small cell lung cancer.
British journal of cancer 2002;86(2):190-5.
2002: Chiun Hsu; Chin-Lun Huang; Hey-Chi Hsu; Po-Huang Lee; Shiou-Jeng Wang; Ann-Lii Cheng
HER-2/neu overexpression is rare in hepatocellular carcinoma and not predictive of anti-HER-2/neu regulation of cell growth and chemosensitivity.
Cancer 2002;94(2):415-20.
2001: Chiun Hsu; Chi-Ling Chen; Li-Tzong Chen; H T Liu; Yee-Chun Chen; C M Jan; C S Liu; Ann-Lii Cheng
Comparison of MALT and non-MALT primary large cell lymphoma of the stomach: does histologic evidence of MALT affect chemotherapy response?
Cancer 2001;91(1):49-56.
2000: H T Liu; Chiun Hsu; Chi-Ling Chen; IP Chiang; Li-Tzong Chen; Yee-Chun Chen; Ann-Lii Cheng
Chemotherapy alone versus surgery followed by chemotherapy for stage I/IIE large-cell lymphoma of the stomach.
American journal of hematology 2000;64(3):175-9.
1999: Chiun Hsu; Ming-Tsan Lin; Jih-Luh Tang; Hwei-Fang Tien; Chiu-Hwa Wang; Yee-Chun Chen
Allogeneic stem cell transplantation for patients with high-risk myelodysplastic syndrome.
Journal of the Formosan Medical Association = Taiwan yi zhi 1999;98(3):157-64.
1998: Ann-Lii Cheng; Kun-Huei Yeh; Jaw-Town Lin; Chiun Hsu; M Y Liu
Cisplatin, etoposide, and weekly high-dose 5-fluorouracil and leucovorin infusion (PE-HDFL)--a very effective regimen with good patients' compliance for advanced gastric cancer.
Anticancer research 1998;18(2B):1267-72.
1997: Chiun Hsu; Kun-Huei Yeh; Ruey-Long Hong; Chang-Hao Yang; Ming-Tsan Lin; Yee-Chun Chen; Ann-Lii Cheng
MVP (mitomycin-C, vinblastine, cisplatin) salvage chemotherapy for relapsed and refractory metastatic breast cancer.
Journal of the Formosan Medical Association = Taiwan yi zhi 1997;96(3):185-8.